Results 211 to 220 of about 14,494 (232)

Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults

Lancet, The, 2004
Esteban Martinez, Felipe Garcia, Jose M Gatell   +2 more
exaly  

Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort.

Journal of Antimicrobial Chemotherapy
A. Ciccullo, G. Baldin, A. Cervo, D. Moschese, F. Lagi, M. Cossu, Alessandro Grimaldi, Andrea Giacomelli, S. Rusconi, G. Sterrantino, A. Borghetti, S. Antinori, C. Mussini, Simona Di Giambenedetto   +13 more
semanticscholar   +1 more source

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

Science, 2010
Anneke C Grobler, Cheryl Baxter, Leila E Mansoor   +2 more
exaly  

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

New England Journal of Medicine, 2019
Willem Venter, Michelle A Moorhouse, Simiso Sokhela   +2 more
exaly  

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

Lancet, The, 2017
Adriano Lazzarin, Chloe Orkin, Daniel Podzamczer   +2 more
exaly  

Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy

AIDS, 2020
openaire   +2 more sources

Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

Science, 2017
Nichole R Klatt, Kenzie Birse, Alexander S Zevin   +2 more
exaly  

Telbivudine/tenofovir-alafenamide/tenofovir-disoproxil-fumarate

Reactions Weekly
openaire   +1 more source

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Lancet, The, 2012
Paul E Sax, Anthony M Mills
exaly  

Birth Outcomes for Pregnant Women with HIV Using Tenofovir–Emtricitabine

New England Journal of Medicine, 2018
Kathryn Rough, ScD, Sonia Hernandez-Diaz, Kunjal Patel   +2 more
exaly